Literature DB >> 15483674

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.

J M de Bont, B van der Holt, A W Dekker, A van der Does-van den Berg, P Sonneveld, R Pieters.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15483674     DOI： 10.1038/sj.leu.2403538

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  67 in total

1.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?

Authors:  Helen M Parsons; Linda C Harlan; Nita L Seibel; Jennifer L Stevens; Theresa H M Keegan
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

3.  Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.

Authors:  Deborah Thomas; Susan O'Brien; Stefan Faderl; Farhad Ravandi; Elias Jabbour; Sherry Pierce; Jorge Cortes; Hagop Kantarjian
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

Review 4.  Pediatric-like therapy for adults with ALL.

Authors:  Hervé Dombret; Thomas Cluzeau; Françoise Huguet; Nicolas Boissel
Journal:  Curr Hematol Malig Rep       Date:  2014-06       Impact factor: 3.952

Review 5.  Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.

Authors:  Hagop Kantarjian; Susan O'Brien; Jorge Cortes; William Wierda; Stefan Faderl; Guillermo Garcia-Manero; Jean-Pierre Issa; Elihu Estey; Michael Keating; Emil J Freireich
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  Differential efficacy of empirical antibiotic therapy for febrile neutropenia in adolescent/young adult (AYA) and child patients.

Authors:  Hirozumi Sano; Ryoji Kobayashi; Daisuke Suzuki; Kenji Kishimoto; Daiki Hori; Satoru Matsushima; Makoto Yoshida; Takeo Sarashina; Naohisa Toriumi; Kunihiko Kobayashi
Journal:  Int J Hematol       Date:  2018-07-23       Impact factor: 2.490

7.  Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trials.

Authors:  Motohiro Kato; Atsushi Manabe; Katsuyoshi Koh; Takeshi Inukai; Nobutaka Kiyokawa; Takashi Fukushima; Hiroaki Goto; Daisuke Hasegawa; Chitose Ogawa; Kazutoshi Koike; Setsuo Ota; Yasushi Noguchi; Akira Kikuchi; Masahiro Tsuchida; Akira Ohara
Journal:  Int J Hematol       Date:  2014-06-18       Impact factor: 2.490

Review 8.  Recent Advances in the Management of Acute Lymphoblastic Leukaemia.

Authors:  Katharine A Hodby; David I Marks
Journal:  Curr Treat Options Oncol       Date:  2020-02-20

9.  Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival.

Authors:  A G Dinmohamed; A Szabó; M van der Mark; O Visser; P Sonneveld; J J Cornelissen; M Jongen-Lavrencic; A W Rijneveld
Journal:  Leukemia       Date:  2015-08-19       Impact factor: 11.528

Review 10.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.